# Elyse S. Rafal, M.D., Stony Brook, NY – FDA Inspections

Source: https://www.keypedia.com/companies/elyse-s-rafal-md/aa8514f3-88d5-4eaf-a609-5b928a2a542c

> Inspection records and compliance data for Elyse S. Rafal, M.D. in Stony Brook, New York. 3 FDA inspections on record, 1 Form 483, last inspected November 24, 2025.

---

## Details

- Name: Elyse S. Rafal, M.D.
- FEI Number: 3027015123
- Business Operations: CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY
- Address Line 1: 2500 Route 347, Building 22a
- City: Stony Brook
- State: New York
- Zip Code: 11790
- Country Name: United States
- Address: 2500 Route 347, Building 22a, Stony Brook, New York 11790, United States
- Country: United States

## Related Documents

- [483 - Elyse S. Rafal, M.D. - 2025-11-24](https://www.keypedia.com/records/483/elyse-s-rafal-md/6d0f532b-adaa-47bc-8802-9a4bbfa0a245) — source: FDA, date: November 24, 2025
- [FDA Inspection 1292742 - Elyse S. Rafal, M.D. - 2025-11-24](https://www.keypedia.com/records/fda_inspections/elyse-s-rafal-md/699fa502-bb8f-452f-9c73-24927d307fa3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 24, 2025
- FDA Inspection 1292742 - Elyse S. Rafal, M.D. - 2025-11-24 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 24, 2025
- FDA Inspection 1247249 - Elyse S. Rafal, M.D. - 2024-08-01 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 1, 2024
- FDA Inspection 1192289 - Elyse S. Rafal, M.D. - 2022-11-17 — classification: No Action Indicated (NAI), source: FDA, date: November 17, 2022

## Related Companies

- [Sarah D. Atkinson, M.D.](https://www.keypedia.com/companies/sarah-d-atkinson-md/b30a86b0-85c7-4013-80e1-6f71c515cc3a)
- [XGen Pharmaceuticals DJB, Inc.](https://www.keypedia.com/companies/xgen-pharmaceuticals-djb-inc/42cd8012-b30d-440e-b2c7-e0d2915c417a)
- [AMA Laboratories, Inc.](https://www.keypedia.com/companies/ama-laboratories-inc/413d7c00-6f30-40f7-9a6b-c7097a991cdc)
- [RIJ Pharmaceutical LLC](https://www.keypedia.com/companies/rij-pharmaceutical-llc/80a63e4c-5df4-4e65-9124-341e9b7c39ee)
- [Mark V. DiBuono, MD](https://www.keypedia.com/companies/mark-v-dibuono-md/d4a83632-9740-40b5-b692-f22b9766a077)
- [Kimball A. Johnson, M.D.](https://www.keypedia.com/companies/kimball-a-johnson-md/ee151a27-f4a7-44c5-84c5-df2f8fe5cca4)
- [AIT Biosciences](https://www.keypedia.com/companies/ait-biosciences/a74cab7a-0526-4454-85d0-0636ebf785c3)
- [Daiichi Sankyo, Inc.](https://www.keypedia.com/companies/daiichi-sankyo-inc/fd789c74-6b2b-43fb-800d-326eceeb1aea)
- [Robert Litman, M.D.](https://www.keypedia.com/companies/robert-litman-md/f4a2d872-0435-4df3-9949-2fda169fc6c3)
- [Dr. Reddy's Laboratories Louisiana LLC](https://www.keypedia.com/companies/dr-reddys-laboratories-louisiana-llc/d4b05fe3-5a6d-4ff1-b907-3f790c763dae)

## Related Officers

- [Roberto A. Dookhan](https://www.keypedia.com/people/roberto-a-dookhan/01c2225f-a885-4421-9967-da323ce55cd8)
